Go
View All
Synthesis phase
Systane Lubricant Eye Drops
System factors, barriers to adherence and
TAGVHD,
TAMs,
Tarceva,
Targeted agents, novel
Targretin,
Tasigna,
T-cell acute lymphoblastic leukemia, notch1 dysregulation and
T-cells
Tear film changes, EGFRI combined with radiation therapy
Telangiectasias
Temsirolimus (Torisel)
TEN,
Teratogenicity, antiangiogenic drugs, nursing considerations and
TGFα
Thalidomide (Thalomid)
Thalidomide derivative agents
Thrombospondin-1 (TSP-1)
Displaying items 961 - 990 of 1092